2-200389272-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001100423.2(SPATS2L):​c.28G>A​(p.Val10Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000021 in 1,431,592 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 1 hom. )

Consequence

SPATS2L
NM_001100423.2 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.421

Publications

0 publications found
Variant links:
Genes affected
SPATS2L (HGNC:24574): (spermatogenesis associated serine rich 2 like) Enables RNA binding activity. Located in cytosol; nucleolus; and nucleoplasm. Part of protein-containing complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.025177151).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPATS2LNM_001100423.2 linkc.28G>A p.Val10Ile missense_variant Exon 3 of 13 ENST00000409140.8 NP_001093893.1 Q9NUQ6-1A0A024R3V0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPATS2LENST00000409140.8 linkc.28G>A p.Val10Ile missense_variant Exon 3 of 13 2 NM_001100423.2 ENSP00000386730.3 Q9NUQ6-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000210
AC:
3
AN:
1431592
Hom.:
1
Cov.:
29
AF XY:
0.00000423
AC XY:
3
AN XY:
709208
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33020
American (AMR)
AF:
0.00
AC:
0
AN:
41034
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25572
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38892
South Asian (SAS)
AF:
0.0000246
AC:
2
AN:
81448
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51842
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5730
European-Non Finnish (NFE)
AF:
9.13e-7
AC:
1
AN:
1094742
Other (OTH)
AF:
0.00
AC:
0
AN:
59312
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 14, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.28G>A (p.V10I) alteration is located in exon 3 (coding exon 1) of the SPATS2L gene. This alteration results from a G to A substitution at nucleotide position 28, causing the valine (V) at amino acid position 10 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
13
DANN
Benign
0.85
DEOGEN2
Benign
0.0035
T;T;T;T;T;T;T;.;T;.;T;T;T;T;.;.;.;.
Eigen
Benign
-0.97
Eigen_PC
Benign
-0.72
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.72
T;.;.;.;T;T;.;T;T;.;T;T;T;T;T;T;T;T
M_CAP
Benign
0.0065
T
MetaRNN
Benign
0.025
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
-1.9
.;N;N;N;.;.;N;N;.;.;.;.;N;.;.;.;.;.
PhyloP100
0.42
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
0.26
N;N;N;N;N;N;N;N;N;N;N;N;N;N;.;N;N;N
REVEL
Benign
0.025
Sift
Benign
1.0
T;T;T;T;T;.;T;T;T;.;T;T;T;T;.;T;T;T
Sift4G
Benign
1.0
T;T;T;T;T;T;T;T;T;.;T;T;T;T;T;.;T;T
Polyphen
0.0, 0.0010
.;B;B;B;.;.;B;B;.;.;.;.;B;.;.;.;.;.
Vest4
0.13, 0.12, 0.12, 0.11
MutPred
0.28
Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);.;.;Loss of methylation at K11 (P = 0.0628);Loss of methylation at K11 (P = 0.0628);
MVP
0.043
MPC
0.22
ClinPred
0.075
T
GERP RS
0.30
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.021
gMVP
0.11
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr2-201253995; COSMIC: COSV62352383; COSMIC: COSV62352383; API